Pantoprazol Aurovitas (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Aurovitas, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Pantoprazol Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazol Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Aurovitas is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Erosive gastritis and duodenal ulcer disease: accelerates the healing of ulcer lesions. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare endocrine disorder. - Prevention of NSA‑induced gastric ulcers: reduces the risk of ulcer formation in patients requiring long‑term NSAID therapy. - Healing of stress‑related mucosal damage in critically intensive‑care patients. - Maintenance therapy after ulcer healing to prevent recurrence.

Pantoprazol Aurovitas is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea or vomiting: occasional. - Abdominal pain or discomfort: transient. - Flatulence: mild gas buildup. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile‑associated colitis: watery diarrhea, abdominal cramping. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: signs of hepatic stress. - Acute interstitial nephritis: kidney inflammation.

Before using Pant​​   ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ​  ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​​ - Assess renal function: adjust use in severe renal impairment. - Evaluate for history of liver disease: monitor hepatic enzymes if indicated. - Review patient’s medication list: avoid concomitant use with drugs that require gastric acidity for absorption. - Monitor long‑term users for bone health: consider calcium and vitamin D supplementation. - Use caution in pregnancy: only if benefits outweigh risks. - Store at ambient temperature: keep in the original packaging, protect from moisture and light.

Pantoprazole may interact ​​  ​  ​   ​  ​  ​   

Major  i   i t   t   t ewline  ewline  ewline \n ewline  ewline  ewline \\